GERD (Gastroesophageal Reflux Disease) Clinical Trials

10 recruitingLast updated: July 25, 2026

There are 10 actively recruiting gerd (gastroesophageal reflux disease) clinical trials across 15 countries. Studies span Not Applicable, Phase 3. Top locations include Warsaw, Masovian Voivodeship, Poland, Batumi, Georgia, Beijing, China. Updated daily from ClinicalTrials.gov.


GERD (Gastroesophageal Reflux Disease) Trials at a Glance

10 actively recruiting trials for gerd (gastroesophageal reflux disease) are listed on ClinicalTrialsFinder across 6 cities in 15 countries. The largest study group is Not Applicable with 6 trials, with the heaviest enrollment activity in Warsaw, Batumi, and Beijing. Lead sponsors running gerd (gastroesophageal reflux disease) studies include Cellmedis, Beijing Friendship Hospital, and Asian Institute of Gastroenterology, India.

Browse gerd (gastroesophageal reflux disease) trials by phase

About GERD (Gastroesophageal Reflux Disease) Clinical Trials

Looking for clinical trials for GERD (Gastroesophageal Reflux Disease)? There are currently 10 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new GERD (Gastroesophageal Reflux Disease) trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about GERD (Gastroesophageal Reflux Disease) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 110 of 10 trials

Recruiting
Not Applicable

QUality of Sleep Improvement With Evening Topical Therapy for Non-Erosive Gastroesophageal Reflux Disease (The QUIET Trial)

GERD (Gastroesophageal Reflux Disease)Non-Erosive Gastro-Esophageal Reflux DiseaseNocturnal Symptoms of GERD+1 more
Cellmedis50 enrolled2 locationsNCT07700342
Recruiting
Not Applicable

New Topical tReatment Options for Symptomatic patiEnts With Nonerosive gastroesophageaL Reflux dIsease (The RELIEF Trial)

GERD (Gastroesophageal Reflux Disease)NERDRegurgitation, Gastric+1 more
Cellmedis50 enrolled1 locationNCT07624383
Recruiting

An Observational Study to Evaluate the Efficacy and Safety of K-CAB Tab./K-CAB ODT(Tegoprazan) in GERD Patients

GERD (Gastroesophageal Reflux Disease)
HK inno.N Corporation5,384 enrolled1 locationNCT07678177
Recruiting
Not Applicable

Safety and Effectiveness of eGERD Device to Reduce Gastroesophageal Reflux Disease (GERD) Symptoms

GERD (Gastroesophageal Reflux Disease)
Gerd Care Medical Ltd84 enrolled5 locationsNCT06613438
Recruiting
Not Applicable

Evaluating Medication Adherence of Patients With Gastroesophageal Reflux Disease With Support of the Smartphone Application GERDCare

GERD (Gastroesophageal Reflux Disease)
Institute of Gastroenterology and Hepatology, Vietnam380 enrolled1 locationNCT07125521
Recruiting
Phase 3

A Study Comparing the Effect and Safety of Linaprazan Glurate to Lansoprazole in Participants With Erosive Esophagitis (EE) Due to Gastroesophageal Reflux Disease (GERD)

GERD (Gastroesophageal Reflux Disease)
Cinclus Pharma Holding AB500 enrolled75 locationsNCT07037875
Recruiting
Not Applicable

TLSA Versus TBSA Surgical Approach for Hiatal Hernia With Gastroesophageal Reflux Disease

GERD (Gastroesophageal Reflux Disease)Hernia, Hiatal
Beijing Friendship Hospital143 enrolled2 locationsNCT07252115
Recruiting
Not Applicable

The Influence of Specialized Food Products Based on Ice-Cream on Esophageal Motility

GERD (Gastroesophageal Reflux Disease)Ineffective Esophageal Motility
Federal State Budgetary Scientific Institution30 enrolled1 locationNCT07121803
Recruiting

Normal Values of Ambulatory 24-hour Oesophageal pH-impedance Monitoring in an Indian Cohort of Participants

GERD (Gastroesophageal Reflux Disease)
Asian Institute of Gastroenterology, India50 enrolled1 locationNCT06928350
Recruiting

"The Voice of Reflux" - Backflow of Gastric Juice Leads to Irritation of the Vocal Folds: Are There Typical Differences in the Voice?

GERD (Gastroesophageal Reflux Disease)Laryngopharyngeal Reflux Disease
Insel Gruppe AG, University Hospital Bern94 enrolled1 locationNCT06495606